Damon Runyon Clinical Investigator Award

  • Limited
  • Anywhere
  • December 7, 2026

Website Damon Runyon Cancer Research Foundation

The Chao Family Comprehensive Cancer Center invites applications for institutional nomination to the 2027 Damon Runyon Clinical Investigator Award, a highly competitive program supporting early-career physician-scientists conducting innovative, patient-oriented cancer research.

This award provides $600,000 over three years ($200,000 per year) to support outstanding early-career physician-scientists committed to translational and clinical research that directly impacts patient care. Indirect costs are not allowed. The Foundation may also repay up to $100,000 in outstanding medical school debt for qualifying awardees.

Award Objectives

The Damon Runyon Clinical Investigator Award is intended to support young physicians who:

  • Conduct innovative, disease-oriented clinical cancer research with the potential to improve patient care.
  • Bridge laboratory discoveries and patient care.
  • Devote 80% protected time to research (exceptions require strong justification).
  • Are committed to careers in clinical, translational, outcomes, epidemiologic, or prevention-oriented research.

Examples of Eligible Research

  • Clinical trials
  • Patient-oriented studies
  • Diagnostic or therapeutic investigations
  • Development of technologies for cancer detection, treatment, or prevention
  • Epidemiologic and behavioral studies
  • Outcomes and health services research

Eligibility

Applicants must meet all criteria:

  • Hold an independent Assistant Professor (or equivalent) position, appointed on or after July 1, 2023.
  • Hold an MD, DO, or MD/PhD degree from an accredited institution.
  • Have completed subspecialty training and be U.S. Board eligible.
  • Hold a valid, active U.S. medical license at the time of application.
  • Commit 80% of full-time professional effort to research.
  • Be nominated by the institution; up to 3 nominations allowed.
  • Must NOT hold an R01 or R01-equivalent grant (such as DP2 or DP5) at the time of application.
  • Must apply with an established mentor in clinical/translational cancer research, cancer prevention, and/or epidemiology.
  • Candidates may apply up to two times during their eligibility period.

To apply for this funding opportunity please visit uci.infoready4.com.

Scroll to Top